Erschienen in:
01.09.2007
Does Intraperitoneal Therapy Have a Role in Recurrent Ovarian Cancer?
verfasst von:
Joanna M. Cain
Erschienen in:
World Journal of Surgery
|
Ausgabe 9/2007
Einloggen, um Zugang zu erhalten
Excerpt
The publication of the increased survival of women with initial intraperitoneal plus intravenous therapy for optimally debulked ovarian cancer over intravenous alone by the Gynecologic Oncology Group (GOG) [
1] has raised the issue of which women might benefit from an intraperitoneal approach beyond initial therapy. However, the significant gastrointestinal, neurotoxic, and hematologic side effects have limited the passion to make this mandatory first-line treatment for women with optimally debulked disease [
2]. …